{"id":"https://openalex.org/W625570628","doi":"https://doi.org/10.1096/fasebj.27.1_supplement.655.1","title":"Novel and potent GPR35 agonists aid identification of residues important in ligand interaction","display_name":"Novel and potent GPR35 agonists aid identification of residues important in ligand interaction","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W625570628","doi":"https://doi.org/10.1096/fasebj.27.1_supplement.655.1","mag":"625570628"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.27.1_supplement.655.1","doi":"https://doi.org/10.1096/fasebj.27.1_supplement.655.1","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.27.1_supplement.655.1","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061886491","display_name":"Amanda E. Mackenzie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Amanda Elaine Mackenzie","raw_affiliation_strings":["Institute of Molecular, Cell and Systems Biology The University of Glasgow GLASGOW United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Molecular, Cell and Systems Biology The University of Glasgow GLASGOW United Kingdom","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050986340","display_name":"Zaynab Neetoo\u2010Isseljee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I109541847","display_name":"LifeArc","ror":"https://ror.org/01dqb0q37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I109541847"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Zaynab Neetoo\u2010Isseljee","raw_affiliation_strings":["MRC Technology Centre for Therapeutics Discovery MRC Technology London United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Technology Centre for Therapeutics Discovery MRC Technology London United Kingdom","institution_ids":["https://openalex.org/I109541847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000101059","display_name":"C. Southern","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I109541847","display_name":"LifeArc","ror":"https://ror.org/01dqb0q37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I109541847"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Craig Southern","raw_affiliation_strings":["MRC Technology Centre for Therapeutics Discovery MRC Technology London United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Technology Centre for Therapeutics Discovery MRC Technology London United Kingdom","institution_ids":["https://openalex.org/I109541847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110005742","display_name":"Jeff C. Jerman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I109541847","display_name":"LifeArc","ror":"https://ror.org/01dqb0q37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I109541847"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jeff Jerman","raw_affiliation_strings":["MRC Technology Centre for Therapeutics Discovery MRC Technology London United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Technology Centre for Therapeutics Discovery MRC Technology London United Kingdom","institution_ids":["https://openalex.org/I109541847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032388950","display_name":"Edward G. McIver","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I109541847","display_name":"LifeArc","ror":"https://ror.org/01dqb0q37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I109541847"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Edward G. McIver","raw_affiliation_strings":["MRC Technology Centre for Therapeutics Discovery MRC Technology London United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Technology Centre for Therapeutics Discovery MRC Technology London United Kingdom","institution_ids":["https://openalex.org/I109541847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064573477","display_name":"Brian D. Hudson","orcid":"https://orcid.org/0000-0001-7059-0091","observed_orcids":["https://orcid.org/0000-0001-7059-0091"]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Brian D. Hudson","raw_affiliation_strings":["Institute of Molecular, Cell and Systems Biology The University of Glasgow GLASGOW United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Molecular, Cell and Systems Biology The University of Glasgow GLASGOW United Kingdom","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110847838","display_name":"Debra L. Taylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I109541847","display_name":"LifeArc","ror":"https://ror.org/01dqb0q37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I109541847"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Debra L. Taylor","raw_affiliation_strings":["MRC Technology Centre for Therapeutics Discovery MRC Technology London United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Technology Centre for Therapeutics Discovery MRC Technology London United Kingdom","institution_ids":["https://openalex.org/I109541847"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051585961","display_name":"Graeme Milligan","orcid":"https://orcid.org/0000-0002-6946-3519","observed_orcids":["https://orcid.org/0000-0002-6946-3519"]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graeme Milligan","raw_affiliation_strings":["Institute of Molecular, Cell and Systems Biology The University of Glasgow GLASGOW United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Molecular, Cell and Systems Biology The University of Glasgow GLASGOW United Kingdom","institution_ids":["https://openalex.org/I7882870"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gpr35","display_name":"GPR35","score":1.0},{"id":"https://openalex.org/keywords/orphan-gpcrs","display_name":"orphan G protein-coupled receptor","score":0.9570000171661377},{"id":"https://openalex.org/keywords/receptor-agonists","display_name":"receptor agonists","score":0.8980000019073486},{"id":"https://openalex.org/keywords/ligand-gated-ion-channels","display_name":"ligand-gated ion channels","score":0.6439999938011169},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8370000123977661},{"id":"https://openalex.org/keywords/ligand-binding-residues","display_name":"ligand binding residues","score":0.6660000085830688},{"id":"https://openalex.org/keywords/site-directed-mutagenesis","display_name":"site-directed mutagenesis","score":0.9359999895095825},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.47600001096725464}],"concepts":[{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.6233649849891663},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5618562698364258},{"id":"https://openalex.org/C169627665","wikidata":"https://www.wikidata.org/wiki/Q5767913","display_name":"Homology modeling","level":3,"score":0.5575594902038574},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.525066077709198},{"id":"https://openalex.org/C16318435","wikidata":"https://www.wikidata.org/wiki/Q149299","display_name":"Mutagenesis","level":4,"score":0.5246527194976807},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.518409013748169},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5128509998321533},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4874601364135742},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.31584084033966064},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2940201759338379},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2816324830055237},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18630662560462952},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.18215101957321167},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.08398988842964172}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1096/fasebj.27.1_supplement.655.1","doi":"https://doi.org/10.1096/fasebj.27.1_supplement.655.1","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.27.1_supplement.655.1","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},{"id":"pmh:oai:eprints.gla.ac.uk:104382","doi":null,"is_oa":false,"landing_page_url":"https://eprints.gla.ac.uk/104382/","pdf_url":null,"source":{"id":"https://openalex.org/S4210235606","display_name":"ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)","issn_l":"2622-8912","issn":["2622-8912","2622-8920"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/I4405259220","host_organization_name":"Institut Agama Islam Negeri Langsa","host_organization_lineage":["https://openalex.org/I4405259220"],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Articles"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310626","display_name":"Center for Advanced Systems and Engineering, Syracuse University","ror":"https://ror.org/025r5qe02"},{"id":"https://openalex.org/F4320334629","display_name":"Biotechnology and Biological Sciences Research Council","ror":"https://ror.org/00cwqg982"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1982830863","https://openalex.org/W3045638775","https://openalex.org/W4361277938","https://openalex.org/W2057885467","https://openalex.org/W2006538807","https://openalex.org/W1982995799","https://openalex.org/W4280599019","https://openalex.org/W4406054256","https://openalex.org/W4210451509","https://openalex.org/W7070664703"],"abstract_inverted_index":{"The":[0],"orphan":[1],"G":[2],"protein":[3],"coupled":[4],"receptor":[5,86],"GPR35":[6,43,102],"has":[7],"emerged":[8],"as":[9],"a":[10,14,96,135],"therapeutic":[11],"target":[12],"in":[13,39,70,101],"number":[15,97],"of":[16,42,60,81,98],"disease":[17],"states":[18],"including":[19],"metabolic":[20],"disorder,":[21],"cardiovascular":[22],"disease,":[23],"inflammation":[24],"and":[25,58,78,85,105,110,121],"nociception.":[26],"Efforts":[27],"to":[28,54,66,123],"characterize":[29],"this":[30],"receptor,":[31],"however,":[32],"have":[33,47],"been":[34],"complicated":[35],"by":[36,134],"marked":[37],"differences":[38,69,107],"the":[40,56,68],"pharmacology":[41,57],"species":[44],"orthologs.":[45,112],"We":[46],"identified":[48],"novel":[49],"agonist":[50],"compounds":[51,63],"with":[52,139],"which":[53,94],"dissect":[55],"function":[59],"GPR35.":[61,82],"Selected":[62],"were":[64],"chosen":[65],"illustrate":[67],"ligand":[71,103],"structure":[72],"activity":[73],"relationship":[74],"between":[75,108],"human,":[76],"mouse":[77],"rat":[79],"orthologs":[80],"Sequence":[83],"alignment":[84],"homology":[87],"modeling":[88],"techniques":[89],"guided":[90],"site":[91],"directed":[92],"mutagenesis,":[93],"highlighted":[95],"residues":[99],"involved":[100],"interaction":[104],"revealed":[106],"rodent":[109],"human":[111],"These":[113],"findings":[114],"will":[115],"benefit":[116],"future":[117],"drug":[118],"development":[119],"programs":[120],"efforts":[122],"generate":[124],"therapeutically":[125],"relevant":[126],"GPR35\u2010specific":[127],"pharmacological":[128],"compounds.":[129],"This":[130],"work":[131],"was":[132],"funded":[133],"BBSRC":[136],"CASE":[137],"studentship":[138],"MRC":[140],"Technology":[141]},"counts_by_year":[],"updated_date":"2026-10-07T09:51:55.459714","created_date":"2016-06-24T00:00:00"}